Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON‐HF Trial
Henri Lu(Brigham and Women's Hospital), Hicham Skali(Dana-Farber/Harvard Cancer Center), Pardeep S. Jhund(Copenhagen University Hospital), John W. Ostrominski(Brigham and Women's Hospital), John J.V. McMurray(University of Glasgow), Alberto Foà(Azienda USL di Bologna), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Amil M. Shah(Brigham and Women's Hospital), Milton Packer(Baylor University Medical Center), Michael R. Zile(Medical University of South Carolina), Scott D. Solomon(Brigham and Women's Hospital), Muthiah Vaduganathan(Brigham and Women's Hospital), Maja Čikeš, Arzu Kalaycı(Brigham and Women's Hospital), Sheila M. Hegde(Brigham and Women's Hospital), Marty Lefkowitz(Novartis (Switzerland)), Akshay S. Desai(Brigham and Women's Hospital), Masatoshi Minamisawa(Brigham and Women's Hospital), Brian Claggett(National Heart Lung and Blood Institute), Jean L. Rouleau(Montreal Heart Institute), Maria Pabón(Brigham and Women's Hospital)
Cited by 12
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k